APG vs. NOV.DE

Last updated Jun 9, 2026

APG (APi Group Corporation) and NOV.DE (Novo Nordisk A/S) are both stocks. APG operates in Engineering & Construction (Industrials), while NOV.DE operates in Biotechnology (Healthcare). Over the past 5 years, APG returned 22.71%/yr vs 4.12%/yr for NOV.DE. At a 0.17 correlation, their price movements are largely independent.

Performance

APG vs. NOV.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in APi Group Corporation (APG) and Novo Nordisk A/S (NOV.DE). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

APG is traded in USD, while NOV.DE is traded in EUR. To make them comparable, the NOV.DE values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, APG achieves a 10.30% return, which is significantly higher than NOV.DE's -11.61% return.

APG

• 1D: 0.52%
• 1M: -4.18%
• YTD: 10.30%
• 6M: 8.48%
• 1Y: 29.87%
• 3Y*: 37.01%
• 5Y*: 22.71%
• 10Y*: —

NOV.DE

• 1D: 4.37%
• 1M: -3.02%
• YTD: -11.61%
• 6M: -5.22%
• 1Y: -38.05%
• 3Y*: -15.34%
• 5Y*: 4.12%
• 10Y*: 9.87%

*Multi-year figures are annualized to reflect compound growth (CAGR)

APG vs. NOV.DE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
APG APi Group Corporation	10.30%	59.55%	3.96%	83.94%	-27.01%	41.98%	74.52%
NOV.DE Novo Nordisk A/S	-11.61%	-38.94%	-14.91%	54.32%	23.37%	59.95%	14.09%

Correlation

The correlation between APG and NOV.DE is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.17
Correlation (3Y) Calculated over the trailing 3-year period	0.17
Correlation (5Y) Calculated over the trailing 5-year period	0.18
Correlation (All Time) Calculated using the full available price history since Apr 30, 2020	0.17

Return for Risk

APG vs. NOV.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

APG

APG Risk / Return Rank: 72
APG Sharpe Ratio Rank: 74
APG Sortino Ratio Rank: 70
APG Omega Ratio Rank: 67
APG Calmar Ratio Rank: 72
APG Martin Ratio Rank: 77

NOV.DE

NOV.DE Risk / Return Rank: 16
NOV.DE Sharpe Ratio Rank: 12
NOV.DE Sortino Ratio Rank: 15
NOV.DE Omega Ratio Rank: 14
NOV.DE Calmar Ratio Rank: 17
NOV.DE Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

APG vs. NOV.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for APi Group Corporation (APG) and Novo Nordisk A/S (NOV.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	APG	NOV.DE	Difference
Sharpe ratio: Return per unit of total volatility	1.08	-0.67	+1.75
Sortino ratio: Return per unit of downside risk	1.67	-0.69	+2.36
Omega ratio: Gain probability vs. loss probability	1.20	0.90	+0.30
Calmar ratio: Return relative to maximum drawdown	1.68	-0.67	+2.35
Martin ratio: Return relative to average drawdown	5.22	-1.00	+6.22
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

APG vs. NOV.DE - Sharpe Ratio Comparison

The current APG Sharpe Ratio is 1.08, which is higher than the NOV.DE Sharpe Ratio of -0.67. The chart below compares the historical Sharpe Ratios of APG and NOV.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	APG	NOV.DE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.08	-0.67	+1.75
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.70	0.11	+0.60
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.29	—
Sharpe Ratio (All Time) Calculated using the full available price history	1.04	0.47	+0.57

Drawdowns

APG vs. NOV.DE - Drawdown Comparison

The maximum APG drawdown since its inception was -49.62%, smaller than the maximum NOV.DE drawdown of -74.69%. Use the drawdown chart below to compare losses from any high point for APG and NOV.DE.

Drawdown Indicators

	APG	NOV.DE	Difference
Max Drawdown Largest peak-to-trough decline	-49.62%	-74.69%	+25.07%
Max Drawdown (1Y) Largest decline over 1 year	-17.83%	-54.35%	+36.52%
Max Drawdown (3Y) Largest decline over 3 years	-21.23%	-74.69%	+53.46%
Max Drawdown (5Y) Largest decline over 5 years	-49.62%	-74.69%	+25.07%
Max Drawdown (10Y) Largest decline over 10 years	—	-74.69%	—
Current Drawdown Current decline from peak	-14.57%	-68.09%	+53.52%
Average Drawdown Average peak-to-trough decline	-10.33%	-12.88%	+2.55%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.74%	36.39%	-30.65%

Volatility

APG vs. NOV.DE - Volatility Comparison

The current volatility for APi Group Corporation (APG) is 7.39%, while Novo Nordisk A/S (NOV.DE) has a volatility of 8.81%. This indicates that APG experiences smaller price fluctuations and is considered to be less risky than NOV.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	APG	NOV.DE	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.39%	8.81%	-1.42%
Volatility (6M) Calculated over the trailing 6-month period	22.05%	40.53%	-18.48%
Volatility (1Y) Calculated over the trailing 1-year period	27.89%	54.66%	-26.77%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	32.53%	38.50%	-5.97%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	33.07%	33.85%	-0.78%

Dividends

APG vs. NOV.DE - Dividend Comparison

APG has not paid dividends to shareholders, while NOV.DE's dividend yield for the trailing twelve months is around 4.11%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
APG APi Group Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOV.DE Novo Nordisk A/S	4.11%	3.54%	1.58%	1.01%	1.17%	1.27%	1.98%	2.08%	27.19%	2.27%	3.67%	1.25%

Financials

Frequently Asked Questions

Can I hold both APG and NOV.DE in my portfolio?

APG and NOV.DE have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.